Agonists at PPAR-γ suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblasts

被引:56
作者
Hao, G-H [1 ,2 ]
Niu, X-L [1 ,2 ]
Gao, D-F [1 ]
Wei, J. [1 ]
Wang, N-P [3 ]
机构
[1] Xian Jiaotong Univ, Sch Med, Affiliated Hosp 2, Dept Cardiol, Xian 710004, Shaanxi, Peoples R China
[2] Xian Jiaotong Univ, Key Lab Environm & Genes Related Dis, Dept Cardiol, Minist Educ, Xian, Shaanxi, Peoples R China
[3] Peking Univ, Hlth Sci Ctr, Inst Cardiovasc Sci, Dept Cardiol, Beijing 100871, Peoples R China
关键词
PPAR-gamma; angiotensin; cardiac fibroblast; plasminogen activator inhibitor-1; extracellular matrix; rosiglitazone; 15d-PGJ(2); fibrosis;
D O I
10.1038/bjp.2008.21
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and purpose: Peroxisome proliferator-activated receptor (PPAR)-gamma ligands have been shown to inhibit cardiac fibrosis. However, the underlying mechanisms are poorly understood. We investigated the regulation by PPAR-gamma ligands of angiotensin (Ang) II-induced plasminogen activator inhibitor (PAI)-1, extracellular matrix (ECM) production and cell growth in cardiac fibroblasts. Experimental approach: The effects of PPAR-gamma ligands on Ang II-induced PAI-1, ECM expression and cell growth were assessed in primary-cultured rat cardiac fibroblasts; cardiac PAI-1 and ECM production was examined in Ang II-infused rats. Key results: In growth-arrested cardiac fibroblasts, PPAR-gamma ligands rosiglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2) (15d-PGJ(2)) dose-dependently attenuated Ang II-induced cell proliferation and expression of PAI-1, collagen type-I, collagen type-III and fibronectin. An accompanying increase in PPAR-gamma expression and activation was also observed. These suppressive effects were attenuated by the PPAR-gamma antagonists GW9662 and bisphenol A diglycidyl ether ( BADGE). Moreover, rosiglitazone and 15d-PGJ(2) inhibited in part the expression and phosphorylation of Ang II-induced transforming growth factor ( TGF)-beta 1, Smad2/3 and c-Jun NH(2)-terminal kinase (JNK). Ang II infusion in rats markedly increased left ventricular production of PAI-1, collagen and fibronectin, with a concurrent increase in the ratios of heart weight/body weight and left ventricle weight/body weight. Co-treatment with rosiglitazone significantly decreased these levels and upregulated PPAR-gamma expression. Conclusions and implications: Rosiglitazone and 15d-PGJ2 suppress Ang II-induced production of PAI-1 and ECM probably via interactions between PPAR-gamma and TGF-beta 1/Smad2/3 and JNK signalling pathways. It is suggested that PPAR-gamma and its ligands may have potential applications in preventing cardiac fibrosis.
引用
收藏
页码:1409 / 1419
页数:11
相关论文
共 52 条
  • [31] Angiotensin II stimulates c-Jun NH2-terminal kinase in cultured cardiac myocytes of neonatal rats
    Kudoh, S
    Komuro, I
    Mizuno, T
    Yamazaki, T
    Zou, YZ
    Shiojima, I
    Takekoshi, N
    Yazaki, Y
    [J]. CIRCULATION RESEARCH, 1997, 80 (01) : 139 - 146
  • [32] Peroxisome proliferator-activated receptor-γ ligands attenuate brain natriuretic peptide production and affect remodeling in cardiac fibroblasts in reoxygenation after hypoxia
    Makino, Naoki
    Sugano, Masahiro
    Satoh, Shinji
    Oyama, Junichi
    Maeda, Toyoki
    [J]. CELL BIOCHEMISTRY AND BIOPHYSICS, 2006, 44 (01) : 65 - 71
  • [33] Ligands of peroxisome proliferator-activated receptor-γ block activation of pancreatic stellate cells
    Masamune, A
    Kikuta, K
    Satoh, M
    Sakai, Y
    Satoh, A
    Shimosegawa, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (01) : 141 - 147
  • [34] Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo
    Nakamura, S
    Nakamura, I
    Ma, LJ
    Vaughan, DE
    Fogo, AB
    [J]. KIDNEY INTERNATIONAL, 2000, 58 (01) : 251 - 259
  • [35] Expression and function of peroxisome proliferator-activated receptor-γ in mesangial cells
    Nicholas, SB
    Kawano, Y
    Wakino, S
    Collins, AR
    Hsueh, WA
    [J]. HYPERTENSION, 2001, 37 (02) : 722 - 727
  • [36] Nissen S.E., 2007, ENGL J MED, V356, P2457
  • [37] Role of c-Jun NH2-terminal kinase in G-protein-coupled receptor agonist-induced cardiac plasminogen activator inhibitor-1 expression
    Omura, T
    Yoshiyama, M
    Matsumoto, R
    Kusuyama, T
    Enomoto, S
    Nishiya, D
    Izumi, Y
    Kim, S
    Ichijo, H
    Motojima, M
    Akioka, K
    Iwao, H
    Takeuchi, K
    Yoshikawa, J
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 38 (04) : 583 - 592
  • [38] PPARγ agonists exert antifibrotic effects in renal tubular cells exposed to high glucose
    Panchapakesan, U
    Sumual, S
    Pollock, CA
    Chen, X
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2005, 289 (05) : F1153 - F1158
  • [39] Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-γ
    Park, KS
    Ciaraldi, TP
    Lindgren, K
    Abrams-Carter, L
    Mudaliar, S
    Nikoulina, SE
    Tufari, SR
    Veerkamp, JH
    Vidal-Puig, A
    Henry, R
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (08) : 2830 - 2835
  • [40] Troglitazone inhibits synthesis of transforming growth factor-β1 and reduces matrix production in human peritoneal mesothelial cells
    Peng, Youming
    Liu, Hong
    Liu, Fuyou
    Liu, Yinghong
    Li, Jun
    Chen, Xing
    [J]. NEPHROLOGY, 2006, 11 (06) : 516 - 523